Anna Šedivá

10PUBLICATIONS
107CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMajor global burdens of diseaseInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 17, 2026
Associations Between Short-Term Changes in Disease Activity and Long-Term Clinical Outcomes in Activated Phosphoinositide 3-Kinase Delta Syndrome.

|Apr 09, 2024
Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome.

V Koneti Rao, Elaine Kulm, Jennifer Grossman

|Nov 08, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Tom Le Voyer, Audrey V Parent, Xian Liu

|Sep 13, 2023
Eosinophils-from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion.

Milos Jesenak, Zuzana Diamant, Dagmar Simon

|Jan 27, 2023
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper.

Wojciech Feleszko, Magdalena Okarska-Napierała, Emilie Pauline Buddingh

|Nov 18, 2022
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome.

V Koneti Rao, Sharon Webster, Anna Šedivá

Pageof 2

Frequent Collaborators

3 joint publications

V Koneti Rao

2 joint publications

Steven Holland

2 joint publications

Michael J Lenardo

2 joint publications

Eva Untersmayr